Antimalarial Drug ToxicityPreventing and Managing Drug-Induced AnaphylaxisBenzodiazepine Poisoning Clinical and Pharmacological Considerations and TreatmentImplementing ecopharmacovigilance in practice: challenges and potential opportunitiesBenefit-Risk Assessment of Fish Oil in Preventing Cardiovascular DiseasePharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal ImpairmentRisk of anaphylaxis with repeated courses of rasburicase: a Research on Adverse Drug Events and Reports (RADAR) projectDrug-induced renal damage in preterm neonates: state of the art and methods for early detectionComparative safety and tolerability of anti-VEGF therapy in age-related macular degenerationMethodology to assess clinical liver safety dataSpecialist Cohort Event Monitoring studies: a new study method for risk management in pharmacovigilanceCardiovascular risk with non-steroidal anti-inflammatory drugs: clinical implicationsLiver safety assessment: required data elements and best practices for data collection and standardization in clinical trialsLiver safety assessment in special populations (hepatitis B, C, and oncology trials)Pharmacokinetic drug interaction profiles of proton pump inhibitors: an updateUseful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal DetectionSafety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative StudiesRisk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational StudiesNeurodevelopmental effects of fetal antiepileptic drug exposureAppropriate Polypharmacy and Medicine Safety: When Many is not Too ManyComparative tolerability of the newer fluoroquinolone antibacterialsUse of antibiotic and analgesic drugs during lactationRisks versus benefits of NSAIDs including aspirin in myocarditis: a review of the evidence from animal studiesIs aspirin a cause of Reye's syndrome?Benefit-risk assessment of rofecoxib in the treatment of osteoarthritisInteraction between aspirin and ACE inhibitors in patients with heart failureAntidepressant discontinuation syndromesNitric oxide-releasing NSAIDs: a review of their current statusThe use of analgesics in patients with asthmaIs aspirin a cause of Reye's syndrome? A case againstInteraction between aspirin and ACE Inhibitors: resolving discrepancies using a meta-analysisAspirin and Reye's syndrome: discovery of aspirin and paracetamolSelective cyclo-oxygenase-2 inhibitors and myocardial infarction: how strong is the link?A benefit-risk assessment of agents used in the secondary prevention of strokeBenefit-risk assessment of treatments for heparin-induced thrombocytopeniaNSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient managementImpact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom: a review of the literatureReye's syndrome: the case for a causal link with aspirinGastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective studyAllergic reactions to medicines derived from Pelargonium species
P1433
Prescribing Variation in General Practices in England Following a Direct Healthcare Professional Communication on MirabegronClinical pharmacist led hospital-wide direct oral anticoagulant stewardship programHealthcare professionals' pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting ratesA pharmacokinetic study of radiprodil oral suspension in healthy adults comparing conventional venous blood sampling with two microsampling techniquesPanvigilance: Integrating Biomarkers in Clinical Trials for Systems PharmacovigilanceWhy Are We Still Creating Individual Case Safety Reports?
P921
Q22061779-B0BF6B63-85E5-47D1-984A-A0CBFAB978A6Q22305843-A4F1542B-90E2-4C95-AFED-32A82143CE89Q22305844-E9020E33-388C-4A56-97A5-516FAA150575Q24608788-183E42E7-0708-42CC-A7DB-3E3C297EA881Q26740486-9C73C360-B318-4FEF-8F3A-8FF791DDAFADQ26751452-8C506D41-E658-4DFA-948C-844F19D51965Q26822723-427ACC40-B4F2-4C11-B23B-0570D7C95849Q26849339-63F7B1B1-8386-4FBE-8815-97BB5B4ECD0CQ26852289-CE1654AF-0C40-48D2-B47A-A5744BB7B0EBQ26853437-4665CCFF-7790-4F0F-8629-39FCEC21D04EQ26998343-813ED1A1-F4C1-4958-91C7-935F068035FAQ27002539-5B41798D-52EE-445F-9DE4-B0609A74CA4CQ27006916-0A854693-305F-4E8C-8244-348EA66276FDQ27008502-DBCECDD5-16C2-41DA-92FC-A175BC8C17CCQ27022254-8DCD2D80-E87D-4621-98D7-21CCD40038AEQ27335410-9B4D6F4E-AB93-4600-8CA6-808048805962Q28069555-CD751490-FECA-4F2E-B6E2-CB9FE140E3E7Q28078747-B2169B73-E586-48E2-8A19-F12DC02789F6Q28080703-91826B30-71BE-4275-9637-0DA4D8C16679Q28087619-553351EE-D751-4E0F-97B5-5AAF97259B62Q28146268-E0FD48EA-83FD-4399-A62F-CAD58C2CECBDQ28165848-567E93DA-2F3C-43EB-A748-DF46E5B9FA2FQ28165851-0074AB08-27BD-4EDE-8A52-C245FF63A350Q28166744-15D09D11-B503-4363-823B-5ED60C8956ACQ28167045-492F0705-942D-48D2-9B37-42659DDF08BFQ28183378-BF3078C0-8062-4B7D-90FF-BB299461BDA0Q28188383-DC8B0374-9CB3-495D-B335-B84F01B57C01Q28190519-11B7DA3D-4AEF-498F-A372-2EE408E80A51Q28190530-5F9C711E-9AD2-44E4-A5EE-768036229234Q28192941-02826EA2-695D-4858-A820-F8F28130B725Q28193032-49D6216F-FDFB-4404-B213-654B501EDA05Q28193560-A851A1B7-AF48-4620-8C26-C7DE1627AA7CQ28193797-926E1668-B2DA-4614-820C-E0E7A95D0661Q28193940-3E784696-AC45-4E84-9DCA-B1E34819B87FQ28196486-96F84F17-9CC5-4847-8A1C-EF68C7FE3408Q28211155-06509CF9-F6EE-4CD5-BFB8-40F1A93987DFQ28211791-560EC0BC-CFF8-4B5C-B429-F980A3BAFAECQ28211899-28662583-2DAA-43EA-B3F1-245528813358Q28212356-B7B21058-59D7-4D5B-B1FB-4B29A8F7346EQ28219407-260D3605-366B-4E93-A125-E6CF06376C5C
P1433
description
journal
@en
publikation
@de
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Springer International Publishing
@nl
مجلة
@ar
वैज्ञानिक पत्रिका
@hi
name
Drug Safety
@da
Drug Safety
@de
Drug Safety
@en
Drug Safety
@es
Drug Safety
@fi
Drug Safety
@fr
Drug Safety
@it
Drug Safety
@nb
Drug Safety
@nl
Drug Safety
@nn
type
label
Drug Safety
@da
Drug Safety
@de
Drug Safety
@en
Drug Safety
@es
Drug Safety
@fi
Drug Safety
@fr
Drug Safety
@it
Drug Safety
@nb
Drug Safety
@nl
Drug Safety
@nn
prefLabel
Drug Safety
@da
Drug Safety
@de
Drug Safety
@en
Drug Safety
@es
Drug Safety
@fi
Drug Safety
@fr
Drug Safety
@it
Drug Safety
@nb
Drug Safety
@nl
Drug Safety
@nn
P243
P3181
P1055
P1058
P1156
P1159
P1277
P1476
Drug Safety
@en
P236
P243
P3181
P407
P495
P571
1990-01-01T00:00:00Z